Thus, the predominant CALCRL-containing receptor in AML is the CGRP receptor, composed of CALCRL and RAMP1; adrenomedullin receptors containing CALCRL and RAMP3 may be present in a minor proportion of patients. Here, CALCRL is linked to acute myeloid leukemia.